Search

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.

… Wednesday, January 5, 2022 The underlying genetic causes of cancer have traditionally been put into one of two categories: Tumors are caused either by somatic mutations, which arise by chance over the course of a person’s life, or by germline mutations, which are inherited at birth from a parent and

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK researchers have found in a laboratory study of lung cancer.

… Wednesday, January 21, 2026 A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment. Targeting this subpopulation of “highly plastic” cells may make current treatments more

Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.

… Friday, January 2, 2026 In cancer research, failure can lead to an important discovery. That’s what happened when an international multicenter trial led by  MSK radiation oncologist and early drug development specialist Nancy Lee, MD , tried combining radiation and chemotherapy with an immunotherapy

Tumors with a biomarker called high microsatellite instability have been linked to inherited cancer mutations.

… Saturday, June 2, 2018 Summary MSK researchers have found that tumors with a particular genetic marker are likely to be associated with Lynch syndrome. Memorial Sloan Kettering researchers have found that the genetic condition Lynch syndrome may be associated with more cancers than earlier thought. Lynch

After treatment for rectal cancer, Roxanne Joseph is back to enjoying an active life with her husband, Rory, and their two children. Recent research by MSK computational biologist Henry Walch is shedding light on why colorectal cancer has been more difficult to treat in many Black people.

… Saturday, July 1, 2023 By Jim Stallard At first, Roxanne Joseph thought she was just hitting the gym weights too hard. The Brooklyn police officer was in top physical condition at age 41 and felt great. But after noticing blood in her stool, she remembered her uncle’s colorectal cancer diagnosis four

Después de recibir tratamiento para el cáncer de recto, Roxanne Joseph ha vuelto a disfrutar de una vida activa junto a su marido, Rory, y sus dos hijos. Una investigación reciente realizada por Henry Walch, biólogo computacional del MSK, está arrojando luz sobre por qué el cáncer colorrectal ha sido más difícil de tratar en muchas personas de raza negra.

… Saturday, July 1, 2023 Por Jim Stallard Al principio, Roxanne Joseph pensó que estaba exagerando con las pesas en el gimnasio. La oficial de policía de Brooklyn estaba en óptimas condiciones físicas a los 41 años y se sentía muy bien. Pero después de notar sangre en sus heces, recordó el diagnóstico

A new immunotherapy approach involves engineering CAR T cells to produce proteins that treat lymphoma.

… Thursday, September 29, 2016 Summary Researchers have modified CAR T cells to produce a protein called HVEM that could treat lymphoma . When injected, the cells naturally zero in on the location of the cancer cells and churn out HVEM continuously for several days. This new immunotherapy approach could

Meet Tiffany Traina, a breast medical oncologist and the Vice Chair of the Department of Medicine at Memorial Sloan Kettering.

… Friday, April 2, 2021 Summary Tiffany A. Traina, MD , is Vice Chair of the Department of Medicine and has been a medical oncologist on the Breast Medicine Service since 2006. She is also the Section Head of the Triple Negative Breast Cancer Clinical Research Program in which she works to develop new

Unlike the clinical management of other types of cancer, a multidisciplinary approach is not the established norm for treating skin cancer, resulting in significantly limited opportunities to individualize patient care.

… Thursday, June 14, 2018 Unlike the clinical management of other types of cancer, a multidisciplinary approach is not the established norm for treating skin cancer, resulting in significantly limited opportunities to individualize patient care. A recent study by our group, and set to be published in the

Memorial Sloan Kettering's new chief nurse Tracy Gosselin says she was taken by surprise when she was asked to consider MSK's top nursing job.

… Thursday, May 5, 2022 Tracy Gosselin says she was taken by surprise when she got the call asking her to consider applying for the top nursing job at Memorial Sloan Kettering Cancer Center (MSK).  “I laughed and said, ‘I can give you lots of names,’ ” she recalls. After careful thought and consultation